Risk Perception in Multiple Sclerosis: Reasons for Switching Treatment Between High Efficacy and Non-high Efficacy Disease-modifying Therapies (P3-4.004)Gustavo Seifer,Patricia Dominguez Castro,James Pike,Eddie Jones,Rainel Sanchez-De La RosaNeurology(2022)引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要